These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 34996385)
21. Association of fecal short-chain fatty acids with clinical severity and gut microbiota in essential tremor and its difference from Parkinson's disease. Huang P; Zhang P; Du J; Gao C; Liu J; Tan Y; Chen S NPJ Parkinsons Dis; 2023 Jul; 9(1):115. PubMed ID: 37460569 [TBL] [Abstract][Full Text] [Related]
22. Serum BDNF discriminates Parkinson's disease patients with depression from without depression and reflect motor severity and gender differences. Huang Y; Huang C; Zhang Q; Wu W; Sun J J Neurol; 2021 Apr; 268(4):1411-1418. PubMed ID: 33179143 [TBL] [Abstract][Full Text] [Related]
23. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway. Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030 [TBL] [Abstract][Full Text] [Related]
24. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease. Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953 [TBL] [Abstract][Full Text] [Related]
25. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model. Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966 [TBL] [Abstract][Full Text] [Related]
26. The correlation of non-motor symptoms and sleep on balance in Parkinson's disease patients with normal cognition and mild cognitive impairment. Saricaoglu M; Yilmaz NH; Ozer FF; Hanoglu L Ir J Med Sci; 2021 Nov; 190(4):1577-1584. PubMed ID: 33449322 [TBL] [Abstract][Full Text] [Related]
27. Gut bacterial profiles in Parkinson's disease: A systematic review. Li Z; Liang H; Hu Y; Lu L; Zheng C; Fan Y; Wu B; Zou T; Luo X; Zhang X; Zeng Y; Liu Z; Zhou Z; Yue Z; Ren Y; Li Z; Su Q; Xu P CNS Neurosci Ther; 2023 Jan; 29(1):140-157. PubMed ID: 36284437 [TBL] [Abstract][Full Text] [Related]
28. Impaired gut barrier integrity and reduced colonic expression of free fatty acid receptors in patients with Parkinson's disease. Liao PH; Tung HY; Lim WS; Jang JR; Li H; Shun CT; Chiu HM; Wu MS; Lin CH Neurol Sci; 2024 Nov; 45(11):5297-5307. PubMed ID: 38862654 [TBL] [Abstract][Full Text] [Related]
29. Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease. Sun BH; Wang T; Li NY; Wu Q; Qiao J World J Gastrointest Pharmacol Ther; 2021 Jan; 12(1):21-31. PubMed ID: 33564494 [TBL] [Abstract][Full Text] [Related]
30. The gut microbiota metabolite propionate ameliorates intestinal epithelial barrier dysfunction-mediated Parkinson's disease via the AKT signaling pathway. Huang T; Shi H; Xu Y; Ji L Neuroreport; 2021 Feb; 32(3):244-251. PubMed ID: 33470765 [TBL] [Abstract][Full Text] [Related]
31. Cognition, motor symptoms, and glycolipid metabolism in Parkinson's disease with depressive symptoms. Yao C; Niu L; Fu Y; Zhu X; Yang J; Zhao P; Sun X; Ma Y; Li S; Li J J Neural Transm (Vienna); 2022 Jun; 129(5-6):563-573. PubMed ID: 34837534 [TBL] [Abstract][Full Text] [Related]
32. Interplay of human gastrointestinal microbiota metabolites: Short-chain fatty acids and their correlation with Parkinson's disease. Liu J; Chen Q; Su R Medicine (Baltimore); 2024 Apr; 103(17):e37960. PubMed ID: 38669388 [TBL] [Abstract][Full Text] [Related]
33. Predictors of depressive symptoms among spouse caregivers in Parkinson's disease. Fernandez HH; Tabamo RE; David RR; Friedman JH Mov Disord; 2001 Nov; 16(6):1123-5. PubMed ID: 11748746 [TBL] [Abstract][Full Text] [Related]
36. Gut brain axis: an insight into microbiota role in Parkinson's disease. Moustafa SA; Mohamed S; Dawood A; Azar J; Elmorsy E; Rizk NAM; Salama M Metab Brain Dis; 2021 Oct; 36(7):1545-1557. PubMed ID: 34370175 [TBL] [Abstract][Full Text] [Related]
37. Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors. Nomura M; Nagatomo R; Doi K; Shimizu J; Baba K; Saito T; Matsumoto S; Inoue K; Muto M JAMA Netw Open; 2020 Apr; 3(4):e202895. PubMed ID: 32297948 [TBL] [Abstract][Full Text] [Related]
38. The Association Between the Gut Microbiota and Parkinson's Disease, a Meta-Analysis. Shen T; Yue Y; He T; Huang C; Qu B; Lv W; Lai HY Front Aging Neurosci; 2021; 13():636545. PubMed ID: 33643026 [TBL] [Abstract][Full Text] [Related]
39. The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism. Yi ZY; Chen L; Wang Y; He D; Zhao D; Zhang SH; Yu R; Huang JH Acta Diabetol; 2022 Oct; 59(10):1295-1308. PubMed ID: 35857109 [TBL] [Abstract][Full Text] [Related]
40. [Correlation analysis of serum calcium level and cognition in the patients with Parkinson's disease]. Liu J; Zhou XP; Zhang L; Zhang Q; Liu CF; Luo WF Zhonghua Yi Xue Za Zhi; 2016 Nov; 96(41):3284-3288. PubMed ID: 27852371 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]